Literature DB >> 26044234

Impact of stent over-expansion at distal edge: insights from a 12-month follow-up study.

K-M Lin1, D-H He, W-H Li.   

Abstract

OBJECTIVE: Although the use of drug-eluting stents has significantly reduced the incidence of restenosis and target lesion revascularization, in-stent and in-segment restenosis remain clinically challenging problems, the underlying mechanisms of which remain unknown. This study aimed to explore the outcomes of different stenting strategies in target vessels with different proximal and distal reference diameters (∆D ≥ 0.25 mm). PATIENTS AND METHODS: In this prospective clinical study, 167 patients undergoing percutaneous coronary intervention with ∆D ≥ 0.25 mm according to QCA results were randomized into 2 groups. Group A (n = 85) was treated by a single stent with high-pressure balloon inflation. Group B (n = 82) was treated by a single stent, with high- and low-pressure balloon inflation at the proximal and distal segment, respectively. The target vessel size and late lumen loss were determined by angiographic analysis.
RESULTS: Compared with normal expansion, overexpansion increased the early minimum lumen diameter (A: 2.40 ± 0.18 mm vs. 2.89 ± 0.21 mm; B: 2.45 ± 0.14 mm vs. 2.49 ± 0.24 mm, p < 0.001), but also increased the percentage of late lumen loss (A: 18.22 ± 0.56%; B: 5.63 ± 0.41%, p < 0.001). Although the total restenosis ratio was similar in 2 groups, the incidence of late lumen loss of group A was higher than that of group B.
CONCLUSIONS: Stent overexpansion increased the early minimum lumen diameter, but also increased the occurrence of late lumen loss at the distal edge of the stent.

Entities:  

Mesh:

Year:  2015        PMID: 26044234

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  Effectiveness and Safety of Compound Chinese Medicine plus Routine Western Medicine in In-Stent Restenosis: A Meta-Analysis and Systematic Review.

Authors:  Lu Liu; Jing Liu; Qun Gao; Yang Wu; Jinjin Lu; Jie Wan; Yan Li; Xiaoyun Cui; Kun Zhou; Wenhao Jia; Yanchao Huang; Wenbai Qu; Qian Lin
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

2.  Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies.

Authors:  Robert J Gil; Jacek Bil; Adam Kern; Luis A Iñigo-Garcia; Radoslaw Formuszewicz; Slawomir Dobrzycki; Dobrin Vassilev; Roxana Mehran
Journal:  Cardiovasc Ther       Date:  2020-01-21       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.